Stocktoria
Progyny, Inc. PGNY
Nasdaq · XNAS · stock · Services-Misc Health & Allied Services, NEC · website · IPO 2019-10-25
Progyny, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 23.6% | 21.7% | 21.9% | 21.3% | 22.4% |
| Operating margin | 6.6% | 5.8% | 5.7% | 3.0% | 6.5% |
| Net margin | 4.5% | 4.7% | 5.7% | 3.9% | 13.1% |
| FCF margin | 14.9% | 14.9% | 17.0% | 9.8% | 4.8% |
| Return on assets | 7.9% | 9.0% | 8.2% | 5.6% | 18.4% |
| Return on equity | 11.3% | 12.9% | 11.2% | 8.1% | 26.1% |
| Current ratio | 2.73 | 2.80 | 3.44 | 2.72 | 2.62 |
| Revenue growth | 10.4% | 7.2% | 38.3% | 57.2% | 45.2% |
Source: SEC EDGAR filings · CIK 0001551306 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.